McCarter & English, LLP
Dihydropyrrolopyridine inhibitors of RORγ
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders. 
Vitae Pharmaceuticals, Inc.
A A A A A A A A A A A A A C A A A A A A A A A A A A A A A A A A A A
A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Colin M. Andrew Lanqi Stephen D. Yi Wei Lawrence Wayne Yajun Jing Linghang Chengguo David A. Suresh B.
Tice Marcus Jia Lotesta Fan Zhao Dillard Zheng Yuan Zhuang Dong Claremon Singh